ResearcherHiroshima UniversityNo recent work listed

Takuya Sakoda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6355-9766; OpenAlex author ID A5076050978. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated with surgical resection and perioperative … Co-author DOI 10.1016/j.pan.2022.03.018 ↗
Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Resectability Status. Co-author DOI 10.1007/s11605-021-04978-3 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yoshiaki Murakami · 2 shared papers, 2021–2022 · strength 0.29
- Paper Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated wi… DOI 10.1016/j.pan.2022.03.018 ↗
- Paper Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Rese… DOI 10.1007/s11605-021-04978-3 ↗
Tatsuaki Sumiyoshi · 2 shared papers, 2021–2022 · strength 0.29
- Paper Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated wi… DOI 10.1016/j.pan.2022.03.018 ↗
- Paper Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Rese… DOI 10.1007/s11605-021-04978-3 ↗
Kenjiro Okada · 2 shared papers, 2021–2022 · strength 0.29
- Paper Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated wi… DOI 10.1016/j.pan.2022.03.018 ↗
- Paper Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Rese… DOI 10.1007/s11605-021-04978-3 ↗
Hiroyuki Otsuka · 2 shared papers, 2021–2022 · strength 0.29
- Paper Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated wi… DOI 10.1016/j.pan.2022.03.018 ↗
- Paper Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Rese… DOI 10.1007/s11605-021-04978-3 ↗
Shin’ya Takahashi · 2 shared papers, 2021–2022 · strength 0.29
- Paper Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated wi… DOI 10.1016/j.pan.2022.03.018 ↗
- Paper Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Rese… DOI 10.1007/s11605-021-04978-3 ↗
Naru Kondo · 2 shared papers, 2021–2022 · strength 0.29
- Paper Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated wi… DOI 10.1016/j.pan.2022.03.018 ↗
- Paper Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Rese… DOI 10.1007/s11605-021-04978-3 ↗
Kenichiro Uemura · 2 shared papers, 2021–2022 · strength 0.29
- Paper Impact of disintegrin and metalloproteinase domain-containing protein 12 on pancreatic ductal adenocarcinoma treated wi… DOI 10.1016/j.pan.2022.03.018 ↗
- Paper Prognostic Value of Peritoneal Lavage Cytology in Patients with Pancreatic Ductal Adenocarcinoma Stratified by the Rese… DOI 10.1007/s11605-021-04978-3 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.